MARKETS
SECTOR : PHARMA & BIOTECH
INDUSTRY : BIOTECH
ENTRADA THERAPEUTICS INC

Entrada Therapeutics Inc

XNAS: TRDA

6.83 -0.49 (-6.69%)

58.48% Fall from 52W High

779.1K

XNAS Volume

XNAS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Entrada Therapeutics Inc is on 19 May 2026 for the purpose of H.C. Wainwright 4th Annual BioConnect Investor Conference See details

Entrada Therapeutics Inc - TRDA - stock price prediction, stock price target, analyst ratings from 8 analysts

Entrada Therapeutics Inc has a share price target of US$ 20, revenue growth forecast of -46.0%, and profit growth estimate of -21.8% for FY26, based on top 8 analyst calls.

58.48% Fall from 52W High

Entrada Therapeutics Inc - TRDA - stock price prediction, stock price target, analyst ratings from 8 analysts

Entrada Therapeutics Inc has a share price target of US$ 20, revenue growth forecast of -46.0%, and profit growth estimate of -21.8% for FY26, based on top 8 analyst calls.

Forecaster Screeners